| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
85,300,000 |
| Market
Cap: |
46.36(B) |
| Last
Volume: |
445,984 |
Avg
Vol: |
482,204 |
| 52
Week Range: |
$391.37 - $576.87 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 532 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile IDEXX Laboratories develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing markets. Co. operates primarily through three business segments: Companion Animal Group, which provides diagnostic and information management-based products and services for the veterinary market; Water Quality Products, which provides testing solutions for detection and quantification of various microbiological parameters in water; and Livestock, Poultry and Dairy, which provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
9,508 |
71,796 |
134,648 |
200,425 |
| Total Sell Value |
$5,316,023 |
$39,916,425 |
$71,573,410 |
$100,536,679 |
| Total People Sold |
2 |
5 |
7 |
10 |
| Total Sell Transactions |
2 |
7 |
12 |
28 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Henderson Rebecca M |
Director |
– • – |
2020-05-13 |
4 |
S |
$286.66 |
$3,840,052 |
D/D |
(13,396) |
14,696 |
|
-27% |
|
| Henderson Rebecca M |
Director |
– • – |
2020-05-13 |
4 |
OE |
$63.95 |
$861,095 |
D/D |
13,396 |
22,118 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-12 |
4 |
S |
$293.41 |
$8,802,300 |
I/I |
(30,000) |
48,000 |
|
-23% |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
794,467 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-11 |
4 |
S |
$297.80 |
$5,956,000 |
I/I |
(20,000) |
78,000 |
|
-22% |
|
| Polewaczyk James F |
Executive Vice President |
• – – |
2020-05-11 |
4 |
S |
$298.28 |
$4,860,515 |
D/D |
(16,264) |
17,772 |
|
-22% |
|
| Polewaczyk James F |
Executive Vice President |
• – – |
2020-05-11 |
4 |
OE |
$62.00 |
$1,212,260 |
D/D |
16,264 |
21,800 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-08 |
4 |
S |
$290.59 |
$6,162,059 |
D/D |
(21,130) |
810,467 |
|
-23% |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-08 |
4 |
OE |
$62.00 |
$1,310,060 |
D/D |
21,130 |
831,597 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-07 |
4 |
S |
$292.25 |
$3,214,750 |
I/I |
(11,000) |
98,000 |
|
-29% |
|
| Szostak M Anne |
Director |
– • – |
2020-05-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
17,518 |
10,217 |
|
- |
|
| Szostak M Anne |
Director |
– • – |
2020-05-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
16,934 |
0 |
|
- |
|
| Szostak M Anne |
Director |
– • – |
2020-05-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
584 |
0 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-06 |
4 |
S |
$286.07 |
$3,890,552 |
I/I |
(13,600) |
109,000 |
|
-32% |
|
| Ayers Jonathan W |
Director |
– • – |
2020-05-04 |
4 |
S |
$268.34 |
$4,025,100 |
I/I |
(15,000) |
122,600 |
|
-34% |
|
| Polewaczyk James F |
Executive Vice President |
• – – |
2020-02-27 |
4 |
OE |
$79.54 |
$99,902 |
D/D |
1,256 |
17,749 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-25 |
4 |
OE |
$79.54 |
$99,902 |
D/D |
1,256 |
810,467 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-21 |
4 |
S |
$280.40 |
$112,160 |
I/I |
(400) |
137,600 |
|
-20% |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
650 |
809,211 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-20 |
4 |
S |
$280.34 |
$6,554,950 |
D/D |
(23,000) |
809,861 |
|
-17% |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-20 |
4 |
OE |
$62.00 |
$1,426,000 |
D/D |
23,000 |
832,861 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-19 |
4/A |
S |
$288.00 |
$11,493,155 |
D/D |
(39,143) |
809,861 |
|
- |
|
| Ayers Jonathan W |
Director |
– • – |
2020-02-19 |
4 |
S |
$288.00 |
$11,493,155 |
D/D |
(39,143) |
810,361 |
|
-13% |
|
| Vandebroek Sophie V. |
Director |
– • – |
2020-02-18 |
4 |
S |
$286.89 |
$2,171,202 |
D/D |
(7,568) |
3,321 |
|
-13% |
|
| Vandebroek Sophie V. |
Director |
– • – |
2020-02-18 |
4 |
OE |
$63.95 |
$590,505 |
D/D |
7,568 |
9,223 |
|
- |
|
867 Records found
|
|
Page 16 of 35 |
|
|
2.51 (0.46%) 
